BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34958672)

  • 21. Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis.
    Zheng X; Sun Y; Ye K; Fan C; Wang X; Yang Y; Jiao R; Ge H
    Thorac Cancer; 2021 Mar; 12(6):899-905. PubMed ID: 33529496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
    Ogawa Y; Shibamoto Y; Hashizume C; Kondo T; Iwata H; Tomita N; Ogino H
    Radiat Oncol; 2018 Jul; 13(1):136. PubMed ID: 30055636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.
    Gutkin PM; Gore E; Charlson J; Neilson JC; Johnstone C; King DM; Hackbarth DA; Wooldridge A; Mannem R; Bedi M
    Radiat Oncol; 2023 Mar; 18(1):42. PubMed ID: 36859309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.
    Sittenfeld SMC; Juloori A; Reddy CA; Stephans KL; Videtic GMM
    Clin Lung Cancer; 2021 May; 22(3):e360-e365. PubMed ID: 32624412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease.
    Osti MF; Agolli L; Valeriani M; Reverberi C; Bracci S; Marinelli L; De Sanctis V; Cortesi E; Martelli M; De Dominicis C; Minniti G; Nicosia L
    Lung Cancer; 2018 Aug; 122():165-170. PubMed ID: 30032826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy.
    Crabtree TD; Puri V; Robinson C; Bradley J; Broderick S; Patterson GA; Liu J; Musick JF; Bell JM; Yang M; Meyers BF
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1183-1191; discussion 1191-2. PubMed ID: 24507980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic Body Radiation Therapy for Salvage Treatment of Recurrent Non-Small Cell Lung Cancer.
    Kowalchuk RO; Waters MR; Richardson KM; Spencer KM; Larner JM; Kersh CR
    Pract Radiat Oncol; 2020; 10(6):e475-e484. PubMed ID: 32454175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?
    Merino Lara T; Helou J; Poon I; Sahgal A; Chung HT; Chu W; Soliman H; Ung Y; Verma S; Cheema P; Cheng S; Khanna S; Erler D; Zhang L; Cheung P
    Lung Cancer; 2018 Oct; 124():219-226. PubMed ID: 30268464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
    Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
    Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
    Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
    Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose hilar and mediastinal stereotactic body radiation therapy for non-small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment.
    Kowalchuk RO; Waters MR; Richardson M; Spencer K; Larner JM; Kersh CR
    Thorac Cancer; 2020 Jul; 11(7):2005-2013. PubMed ID: 32469465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial.
    Tate MK; Hernandez M; Chang JY; Lin SH; Liao Z; Koshy SM; Skinner HD; Chun SG
    Anticancer Res; 2024 Jan; 44(1):133-137. PubMed ID: 38159979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy.
    Tan D; Gill S; Loh N
    Cancer Med; 2020 Oct; 9(20):7469-7476. PubMed ID: 32846054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
    Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
    Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study.
    Jia Z; Fang F; Cao Y; Zhu X; Yang X; Guo X; Zhang H
    Radiat Oncol; 2023 Aug; 18(1):140. PubMed ID: 37620952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    Wang X; Zamdborg L; Ye H; Grills IS; Yan D
    BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
    Ma SJ; Serra LM; Syed YA; Hermann GM; Gomez-Suescun JA; Singh AK
    Clin Lung Cancer; 2018 Mar; 19(2):e235-e240. PubMed ID: 29153897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.